Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 625.00 | 384.25 | 494.00 | 823.25 | 0.6001 | 0.2568 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 900.00 | 823.25 | 1.0932 | 1.1689 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 994.00 | 823.25 | 1.2074 | 1.3741 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 384.25 | 722.00 | 823.25 | 0.8770 | 0.7749 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 625.00 | 384.25 | 420.00 | 823.25 | 0.5102 | 0.0843 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 606.00 | 823.25 | 0.7361 | 0.5135 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 765.00 | 823.25 | 0.9292 | 0.8709 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 625.00 | 384.25 | 368.00 | 823.25 | 0.4470 | -0.0385 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 855.00 | 823.25 | 1.0386 | 1.0700 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 927.00 | 823.25 | 1.1260 | 1.2280 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 667.00 | 823.25 | 0.8102 | 0.6515 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 625.00 | 384.25 | 452.00 | 823.25 | 0.5490 | 0.1592 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 738.00 | 823.25 | 0.8965 | 0.8107 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 666.00 | 823.25 | 0.8090 | 0.6493 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1714.00 | 2189.25 | 0.7829 | 0.6547 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1725.00 | 2189.25 | 0.7879 | 0.6630 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2037.00 | 2189.25 | 0.9305 | 0.8914 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 934.00 | 2189.25 | 0.4266 | 0.0341 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 1250.00 | 894.42 | 1695.00 | 2189.25 | 0.7742 | 0.6405 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2035.00 | 2189.25 | 0.9295 | 0.8900 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 903.00 | 2189.25 | 0.4125 | 0.0074 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 1250.00 | 894.42 | 1944.00 | 2189.25 | 0.8880 | 0.8242 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 1250.00 | 894.42 | 1953.00 | 2189.25 | 0.8921 | 0.8308 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2481.00 | 2189.25 | 1.1333 | 1.2034 | |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 1250.00 | 894.42 | 1946.00 | 2189.25 | 0.8889 | 0.8257 |